A drug developed in Corvallis and Perth, Australia, to treat a genetic disorder may also represent a promising advance in personalized medicine.
Neither Jennifer Fox nor Robbie Allen is a poet. But when explaining their work to others, these scientists often rely on that pillar of poetry, the metaphor. That’s because for most people, picturing needles in haystacks, keys in locks, and spaceships in docks is a lot easier than getting a clear image of high-throughput screening, combinatorial chemistry, 3D virtual screening or other esoterica in the field of drug discovery.
By some estimates, a third to half of the artesunate, an anti-malarial drug, in some countries is counterfeit. The World Health Organization has called for faster, more accurate tests, and now a team of Oregon State University chemists has stepped up with an innovative approach.